
At ESMO Congress 2026 in Madrid, Gene Solutions hosted its first Industry Satellite Symposium at the main ESMO Congress, bringing clinical validation, real-world experience, and multi-omic innovation generated in Asia into the global oncology conversation.
The full-house symposium, “AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation,” brought together six international faculty members to share scientific and clinical perspectives on the future of cancer detection and precision oncology.
Co-chaired by Prof. Umberto Malapelle of the University of Naples Federico II and Prof. Herbert Ho Fung Loong of The Chinese University of Hong Kong, the program presented a connected, patient-centered scientific journey spanning multi-cancer detection, tissue and liquid-biopsy genomic profiling, molecular monitoring, immunogenetic discovery, and patient-derived 3D tumor organoids.
Rather than viewing these technologies independently, the symposium explored how complementary molecular, biological, longitudinal, and functional information may work together across the cancer care continuum.
Watch the symposium presentations
Access the six faculty presentations and explore the key scientific messages from each session on the K-CONNECT platform.
Prof. Umberto Malapelle
Clinical Challenges with Multi-Cancer Early Detection Tests: Unmet Needs and Lessons for Next-Generation Approaches in Precision Oncology
Explore the analytical, clinical, and implementation challenges shaping multi-cancer screening, including the evidence needed to support responsible clinical adoption.

Watch Prof. Umberto Malapelle’s presentation on K-CONNECT
Dr. Le Son Tran
AI-Enabled Multi-omic Cell-Free DNA Profiling for Multi-Cancer Detection: Technology Challenges, Large Validation Datasets and Pathways to Global and Diverse Implementation
Explore how AI-enabled multi-omic cfDNA profiling was developed and evaluated through retrospective, prospective, and large-scale real-world datasets.

Watch Dr. Le Son Tran’s presentation on K-CONNECT
Prof. Herbert Ho Fung Loong
Multi-Omic Liquid Biopsy Approaches in Precision Oncology: Asian Real-World Evidence on Scale, Affordability and High-Precision Applications
Explore how tissue and liquid biopsy can provide complementary molecular information across genomic profiling, treatment-response assessment, and longitudinal disease monitoring.

Watch Prof. Herbert Ho Fung Loong’s presentation on K-CONNECT
Prof. Aya El Helali
The Role of Multi-Omic Signals for Next-Generation Precision Oncology and Immunogenetic Discovery
Explore how multi-omic information can deepen understanding of tumor biology, the immune microenvironment, neoantigen patterns, and therapeutic hypotheses.

Watch Prof. Aya El Helali’s presentation on K-CONNECT
Dr. Vien Le
3D Patient-Derived Organoids in Precision Medicine: From Bench to Bedside
Explore how patient-derived tumor organoids may add a functional research layer to genomic profiling and how prospective studies are evaluating their concordance with clinical treatment response.

Watch Dr. Vien Le’s presentation on K-CONNECT
Asst. Prof. Lucksamon Thamlikitkul
ctDNA Monitoring in Early-Stage NSCLC: A Real-World Case Experience
Explore a real-world lung cancer case illustrating how longitudinal ctDNA monitoring can complement imaging and tissue profiling, while highlighting the importance of interpreting molecular signals within the patient’s complete clinical history.

Watch Asst. Prof. Lucksamon Thamlikitkul’s case presentation on K-CONNECT
Watch the panel discussion
The symposium concluded with a multidisciplinary discussion on the clinical evidence, infrastructure, access, and implementation pathways required to translate innovation generated across different regions into globally relevant precision oncology.
Hear directly from the faculty
Following the symposium, participating faculty reflected on the scientific discussions, the evolving role of multi-omics, and the steps needed to translate advanced molecular technologies into meaningful and accessible cancer care.
Watch the ESMO 2026 faculty interviews
Explore Gene Solutions’ scientific posters
Gene Solutions, in collaboration with the Medical Genetics Institute, also contributed scientific posters featuring real-world molecular profiling and ctDNA monitoring research from Southeast Asia.
The studies explored how complementary tissue and liquid-biopsy approaches may support more comprehensive molecular profiling and longitudinal disease monitoring across multiple cancer types.
Explore Gene Solutions’ scientific posters
- 4463P – Implementing Comprehensive Genomic Profiling in Southeast Asia: Real-World Feasibility and Performance Across Multiple Cancer Types
- 4455P – Real-World Performance of Dual Tissue and Liquid Biopsy Profiling for Managing Gastrointestinal and Hepatobiliary Cancers in Southeast Asia
Across the programme, one shared direction emerged: the future of precision oncology will require more than any single test or technology.
Gene Solutions presented a patient-centered ecosystem that connects earlier detection, comprehensive genomic profiling, deeper biological and immune understanding, functional investigation of treatment response, and longitudinal ctDNA monitoring around the needs of the same patient.
The next step is to continue expanding prospective clinical validation, strengthening international research collaborations, and generating the evidence needed to translate this integrated approach across diverse healthcare settings.
This non-promotional medical educational symposium was organized and funded by Gene Solutions for healthcare professionals only.


